Title:
ANTI-HUMAN MSLN ANTIBODY AND MSLN-TARGETING IMMUNE EFFECTOR CELL
Document Type and Number:
WIPO Patent Application WO/2022/012097
Kind Code:
A1
Abstract:
The present invention provides an anti-human MSLN-specific antibody and an MSLN-targeting immune effector cell. Also provided is an MSLN-targeting chimeric antigen receptor modified T-cell prepared using the antibody and a use thereof.
Inventors:
HUANG FEI (CN)
PENG TAO (CN)
ZOU XUEMEI (CN)
LIU PINGLEI (CN)
LIU DACHUN (CN)
HUANG HUI (CN)
PENG TAO (CN)
ZOU XUEMEI (CN)
LIU PINGLEI (CN)
LIU DACHUN (CN)
HUANG HUI (CN)
Application Number:
PCT/CN2021/086067
Publication Date:
January 20, 2022
Filing Date:
April 09, 2021
Export Citation:
Assignee:
HRAIN BIOTECHNOLOGY CO LTD (CN)
International Classes:
C07K16/30; A61K39/00; A61K39/395; A61P35/00; C07K19/00; C12N5/10; C12N15/13
Domestic Patent References:
| WO2020011970A1 | 2020-01-16 |
Foreign References:
| CN111560072A | 2020-08-21 | |||
| CN110746508A | 2020-02-04 | |||
| CN109111528A | 2019-01-01 | |||
| CN110507824A | 2019-11-29 |
Attorney, Agent or Firm:
SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC (CN)
Download PDF:
Previous Patent: SELF-ADAPTIVE VERTICALITY MEASURING DEVICE
Next Patent: HYDROGENATION CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF
Next Patent: HYDROGENATION CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF